HopeStage
Back to all studies
RecruitingNCT05734313

Telehealth CBT for anxiety or depression in young adults with type 1 diabetes

About this titleRead the official source — NCT05734313
Device studyAges 18–64United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 64 years.

Listed locations
Boston and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 31, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
94
Sponsor
Albert Einstein College of Medicine
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Device
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT05734313
Official title
Show the full official title

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults With Type 1 Diabetes

Recruitment & locations

Currently recruiting

Boston · The Bronx

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Albert Einstein College of Medicine, a university.

Who can participate?

Listed age limits: 18 years to 64 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies